Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
24 nov. 2020 16h05 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
12 nov. 2020 16h15 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
10 nov. 2020 16h41 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
09 sept. 2020 17h28 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
12 août 2020 16h59 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Vaxcyte, Inc. (Nasdaq: PCVX), please note that in the first bullet under “Recent...
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
12 août 2020 16h10 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
16 juin 2020 16h05 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte Announces Pricing of Upsized Initial Public Offering
12 juin 2020 01h06 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent...
Vaxcyte Appoints Halley E. Gilbert to Board of Directors
03 juin 2020 08h30 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
SutroVax Announces Name Change to Vaxcyte
21 mai 2020 08h30 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- SutroVax, Inc., a next-generation vaccine company, today announced that it has changed its name to Vaxcyte, Inc. The new name more accurately...